ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 271674 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 271674; 2) Community: the network communities that were significantly associated with the response to NSC 271674; 3) Molecule: the relationships between components within communities and NSC 271674; 4) MDR: the compounds that were significantly associated with the NSC 271674.

NSC Compound Enrichment Correlation
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0202245331784477 0.34957795
NSC 726267 Null 0.0202245331784477 -0.091971188
NSC 735030 Null 0.0202245331784477 0.33986912
NSC 736157 Null 0.0202245331784477 -0.10927828
NSC 736811 Null 0.0202245331784477 0.34586077
NSC 740 Methotrexate 0.0202245331784477 0.61376247
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0202245331784477 0.46432276
NSC 756053 Null 0.0202245331784477 -0.31879737
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0202245331784477 0.32691282
NSC 79093 5-Hydroxy-6,7,8,4'-tetramethoxyflavone 0.0202245331784477 0.15500393
Total:112  Current:56    [First] [Prev] [Next] [Last]